Alkermes
ALKS
#3093
Rank
HK$37.94 B
Marketcap
HK$229.80
Share price
0.75%
Change (1 day)
-5.32%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): HK$3.16 Billion

According to Alkermes's latest financial reports the company's current earnings are HK$1.52 Billion. In 2024 the company made an earning of HK$3.63 Billion a decrease over its 2023 earnings that were of HK$4.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$3.16 B-12.94%
2024 HK$3.63 B-17.97%
2023 HK$4.42 B-468.52%
2022 -HK$1.21 Billion449.24%
2021 -HK$0.22 Billion-68.04%
2020 -HK$0.69 Billion-52.1%
2019 -HK$1.43 Billion64.49%
2018 -HK$0.87 Billion-15.04%
2017 -HK$1.03 Billion-34.2%
2016 -HK$1.56 Billion-5.34%
2015 -HK$1.65 Billion35084.97%
2014 -HK$4.67 Million
2012 HK$57.78 M-117.81%
2011 -HK$0.33 Billion-12.69%
2010 -HK$0.38 Billion94.3%
2009 -HK$0.2 Billion-117.7%
2008 HK$1.08 B622.63%
2007 HK$0.14 B
2004 -HK$0.6 Billion-14.48%
2003 -HK$0.7 Billion11.88%
2002 -HK$0.62 Billion39.65%
2001 -HK$0.45 Billion5.73%
2000 -HK$0.42 Billion-28.91%
1999 -HK$0.59 Billion237.28%
1998 -HK$0.18 Billion100.05%
1997 -HK$87.28 Million-37.93%
1996 -HK$0.15 Billion82.72%
1995 -HK$76.95 Million-26.79%
1994 -HK$0.11 Billion-72.78%
1993 -HK$0.39 Billion208.07%
1992 -HK$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Acorda Therapeutics
ACOR
-HK$2.12 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.53 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.18 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.26 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$101.90 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$13.79 B 336.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
-HK$1.66 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$70.84 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
HK$127.81 B 3,947.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland